...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Effects of an Alkaline Diet on EGFR-TKI Therapy in EGFR Mutation-positive NSCLC
【24h】

Effects of an Alkaline Diet on EGFR-TKI Therapy in EGFR Mutation-positive NSCLC

机译:碱性饮食对EGFR-TKI治疗EGFR突变阳性NSCLC的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The acidic tumor microenvironment is associated with progression of cancers. The purpose of this study was to investigate the association between an alkaline diet and the effect of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) in non-small cell lung cancer (NSCLC) patients. Patients and Methods: Eleven advanced or recurrent NSCLC patients with EGFR mutations treated with EGFR-TKI after being instructed to follow an alkaline diet were retrospectively evaluated. Results: The median progression-free survival (PFS) and overall survival (OS) were 19.5 (range= 3.1-33.8) and 28.5 (range= 15.4-46.6) months. The average dosage of EGFR-TKI was 56 +/- 22% of the standard dosage. Urine pH was significantly increased after the alkaline diet (6.00 +/- 0.38 vs. 6.95 +/- 0.55; p< 0.05). Conclusion: An alkaline diet may enhance the effect of EGFR-TKI treatment in NSCLC patients with EGFR mutations.
机译:背景:酸性肿瘤微环境与癌症的进展相关。 本研究的目的是探讨碱性饮食与表皮生长因子受体(EGFR)-TYROSINE激酶抑制剂(TKI)在非小细胞肺癌(NSCLC)患者中的关联。 患者及方法:回顾性评估了在被指示遵循碱性饮食后用EGFR-TKI治疗的EGFR突变的11例高级或复发性NSCLC患者。 结果:中位进展生存期(PFS)和总存活(OS)为19.5(范围= 3.1-33.8),28.5(范围= 15.4-46.6)个月。 EGFR-TKI的平均用量为标准剂量的56 +/- 22%。 碱性饮食后尿pH值明显增加(6.00 +/- 0.38 vs.6.95 +/- 0.55; p <0.05)。 结论:碱性饮食可以增强EGFR-TKI治疗NSCLC患者EGFR突变的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号